Targeted delivery of anticancer drugs is considered to be one of the pillars of cancer
treatment as it could allow for a better treatment efficiency and less adverse effects. A …

Nanomaterials have been the focus of intensive development and research in the medical
and industrial sectors over the past several decades. Some studies have found that these …

Regulating the tumor microenvironment (TME) has been a promising strategy to improve
antitumor therapy. Here, a red blood cell membrane (mRBC)‐camouflaged hollow MnO2 …

Micro and nanoscale drug carriers must navigate through a plethora of dynamic biological
systems prior to reaching their tissue or disease targets. The biological obstacles to drug …

In this study, platelet membrane (PLTM) biomimetic hollow MnO 2 nanoparticles were
prepared and these were investigated for delivery of bufalin. Additionally, these …

Breast cancer contributes to high mortality rates as a result of metastasis. Tumor-derived
exosomes facilitate the development of the premetastatic environment, interacting and …

Nanocarriers play an important role in drug delivery for disease treatment. However,
nanocarriers face a series of physiological barriers after administration such as blood …

Engineered nanomaterials hold promise for a wide range of applications in medicine.
However, safe use of nanomaterials requires that interactions with biological systems, not …

Development of exosome-based delivery systems is still facing some formidable challenges,
including the lack of standardized isolation and purification methods, non-large-scale …

Iron oxide magnetic nanoparticles (IONPs) have attracted enormous attention because of
their extensive medicinal and industrial applicability. PEGylated L-arginine modified iron …